John Hadden

John Hadden is a declared insider of PLx Pharma Inc., with filings sourced from SEC (Form 4). Between 19 April 2017 and 14 December 2020, the trades on record add up to 4 filings.

Purchases make up the whole of the open-market record (3 purchases, €6,791). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant. 2020 to date brings 3 purchases and no sales.

Half of the purchases are above €2,301 and half below. On 3 out of 3 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The latest filing, published on 15 December 2020, reports an open-market purchase of €2,680 in PLx Pharma Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.